ARTICLE | Clinical News
Kcentra 4-factor prothrombin complex concentrate regulatory update
December 23, 2013 8:00 AM UTC
CSL said FDA approved a label expansion for Kcentra to include the urgent reversal of anticoagulation with vitamin K antagonist therapy, including warfarin, in adults needing an urgent surgery or othe...